This association does not seem to be related to obesity, the degree of diabetes control or statin use, because in terms of these three variables, we did not find any significant differences between patients with different AMPD1:rs17602729 genotypes (i.e., with different AMP deaminase 1 activities). Here, AMPD1 is linked to obesity due to melanocortin 4 receptor deficiency.